Miconazole extended-release - Onxeo

Drug Profile

Miconazole extended-release - Onxeo

Alternative Names: BA-001; Loramyc; Miconazole Lauriad 50mg Bioadhesive Extended-Release Buccal Tablets; Miconazole Lauriad Bioadhesive Buccal Tablets; Miconazole Lauriad®; Oravig; Sitamic; SO-1105

Latest Information Update: 08 Mar 2017

Price : $50

At a glance

  • Originator BioAlliance Pharma
  • Developer Onxeo SA; SciClone Pharmaceuticals; Sosei
  • Class Antifungals; Imidazoles; Small molecules
  • Mechanism of Action Cell membrane modulators; Cholesterol synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Oropharyngeal candidiasis

Most Recent Events

  • 28 Feb 2017 Preregistration for Oropharyngeal candidiasis in Japan (Buccal)
  • 21 Sep 2016 Midatech Pharma and R-Pharm agree to co-promote miconazole in USA
  • 05 Oct 2015 DARA BioSciences re-launches Miconazole controlled-release buccal tablet in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top